VM-PAIN-004
An oral repurposed therapeutic in late-stage development for complex regional pain syndrome.
VM-PAIN-003
A novel small-molecule program being developed for severe neuropathic pain, including trigeminal neuralgia.
VM-NEU-003
A selective CNS therapy under development for individuals with treatment-resistant epilepsies.
VM-NEU-002
A novel CNS therapeutic candidate being developed for early Alzheimer’s disease.
VM-NEU-001
A regenerative therapeutic candidate in development for neurodegenerative diseases, beginning with Parkinson’s disease.